ARCHIVE
INVESTING IN JAPANESE REGENERATIVE MEDICINE

*This event has ended.

OVERVIEW

Regenerative Medicine is highly anticipated in Japan from its potential and impact. Many players are participating, among them, venture companies are very active in this field. The event will have insightful discussions, and presentations with government officials, academia and companies focusing on Japanese Regenerative Medicine & Drug Discovery.

AGENDA

13:40 - 14:40

Fireside ChatThe Approach to Clinical Trials and Approvals

KIYOSHI ANDO

Senior Staff Writer
Nikkei Inc.

14:50 - 15:50

PresentationsLeading Japanese Regenerative Medicine & Drug Discovery Venture Companies

15:50 - 16:50

Panel Discussion"The Perspective of Overseas Investors"
An Exchange of Insights Between Overseas Investors and Regenerative Medicine Venture Companies

16:50 - 17:00

Closing Speech

17:00 - 18:00

Networking Reception

*Please be advised that speakers and programs may be subject to change.

OUTLINE

Date & Time:
September 17th (Tue), 2024 13:00-18:00 (Doors Open at 12:30)
Venue:
Nikkei Hall
1-3-7, Otemachi, Chiyoda-ku, Tokyo, Japan（WEBSITE）
Event Format:
In-Person and Online
*Archive Video will be available for the registrants after the event
Language:
English and Japanese
Fee:
Complimentary with Pre-Registration
*Drawing will be held when the application exceeds the planned sheet numbers.
Registration Deadline:
September 6th (Fri) 17:00
Organizer:
NIKKEI Inc.
Endorsement:
Ministry of Health, Labour and Welfare
Sponsor:
  • HESTAOKURA
  • Roche
  • Cantor

REGISTER

*Registration Closed

CONTACT

Use of cookies

By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our Cookie Policy to learn how you can update your cookie settings.

OK
CLOSE